| Added by | mollevi |
|---|---|
| Last modified by | Cavailles |
| Group name | EquipeVC |
| Item Type | Journal Article |
| Title | Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia |
| Creator | Lapierre et al. |
| Author | M. Lapierre |
| Author | A. Castet-Nicolas |
| Author | D. Gitenay |
| Author | S. Jalaguier |
| Author | C. Teyssier |
| Author | C. Bret |
| Author | G. Cartron |
| Author | J. Moreaux |
| Author | V. Cavailles |
| Abstract | RIP140 is a transcriptional coregulator, (also known as NRIP1), which finely tunes the activity of various transcription factors and plays very important physiological roles. Noticeably, the RIP140 gene has been implicated in the control of energy expenditure, behavior, cognition, mammary gland development and intestinal homeostasis. RIP140 is also involved in the regulation of various oncogenic signaling pathways and participates in the development and progression of solid tumors. During the past years, several papers have reported evidences linking RIP140 to hematologic malignancies. Among them, two recent studies with correlative data suggested that gene expression signatures including RIP140 can predict survival in chronic lymphocytic leukemia (CLL). This review aims to summarize the literature dealing with the expression of RIP140 in CLL and to explore the potential impact of this factor on transcription pathways which play key roles in this pathology. |
| Publication | J Hematol Oncol |
| Volume | 8 |
| Pages | 20 |
| Date | 2015 |
| Journal Abbr | Journal of hematology & oncology |
| DOI | 10.1186/s13045-015-0116-6 |
| ISSN | 1756-8722 (Electronic) 1756-8722 (Linking) |
| Tags | review |
| Date Added | 2018/11/14 - 12:10:52 |
| Date Modified | 2019/05/16 - 10:47:15 |
| Notes and Attachments | (Note) (Note) 25879677 (Attachment) |
Institut de Recherche en Cancérologie de
